These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 25747784)
41. Evaluation of risk factors and health outcomes among persons with asthma. Smith K; Warholak T; Armstrong E; Leib M; Rehfeld R; Malone D J Asthma; 2009 Apr; 46(3):234-7. PubMed ID: 19373629 [TBL] [Abstract][Full Text] [Related]
42. Observational study of the effects of using montelukast vs fluticasone in patients matched at baseline. Allen-Ramey FC; Duong PT; Riedel AA; Markson LE; Weiss KB Ann Allergy Asthma Immunol; 2004 Oct; 93(4):373-80. PubMed ID: 15521374 [TBL] [Abstract][Full Text] [Related]
43. Short-acting β-agonist use and its ability to predict future asthma-related outcomes. Stanford RH; Shah MB; D'Souza AO; Dhamane AD; Schatz M Ann Allergy Asthma Immunol; 2012 Dec; 109(6):403-7. PubMed ID: 23176877 [TBL] [Abstract][Full Text] [Related]
44. Asthma-associated comorbidities in children with and without secondhand smoke exposure. Pyle RC; Divekar R; May SM; Narla N; Pianosi PT; Hartz MF; Ott NL; Park MA; McWilliams DB; Green JA; Despins KN; Joshi AY Ann Allergy Asthma Immunol; 2015 Sep; 115(3):205-10. PubMed ID: 26208757 [TBL] [Abstract][Full Text] [Related]
45. Preventable hospitalizations and access to health care. Bindman AB; Grumbach K; Osmond D; Komaromy M; Vranizan K; Lurie N; Billings J; Stewart A JAMA; 1995 Jul; 274(4):305-11. PubMed ID: 7609259 [TBL] [Abstract][Full Text] [Related]
46. Childhood obesity in secondary care: national prospective audit of Australian pediatric practice. Campbell M; Bryson HE; Price AM; Wake M Acad Pediatr; 2013; 13(2):168-76. PubMed ID: 23498083 [TBL] [Abstract][Full Text] [Related]
47. Use of asthma medication dispensing patterns to predict risk of adverse health outcomes: a study of Medicaid-insured children in managed care programs. Farber HJ; Chi FW; Capra A; Jensvold NG; Finkelstein JA; Lozano P; Quesenberry CP; Lieu TA Ann Allergy Asthma Immunol; 2004 Mar; 92(3):319-28. PubMed ID: 15049395 [TBL] [Abstract][Full Text] [Related]
48. Clinical effectiveness of inhaled corticosteroids versus montelukast in children with asthma: prescription patterns and patient adherence as key factors. Ducharme FM; Noya FJ; Allen-Ramey FC; Maiese EM; Gingras J; Blais L Curr Med Res Opin; 2012 Jan; 28(1):111-9. PubMed ID: 22077107 [TBL] [Abstract][Full Text] [Related]
49. Provider practice, overweight and associated risk variables among children from a multi-ethnic underserved community. Hamilton JL; James FW; Bazargan M J Natl Med Assoc; 2003 Jun; 95(6):441-8. PubMed ID: 12856909 [TBL] [Abstract][Full Text] [Related]
50. Relationship of asthma control to asthma exacerbations using surrogate markers within a managed care database. Schatz M; Zeiger RS; Yang SJ; Chen W; Crawford WW; Sajjan SG; Allen-Ramey F Am J Manag Care; 2010 May; 16(5):327-33. PubMed ID: 20469953 [TBL] [Abstract][Full Text] [Related]
51. Immediate health effects of an urban wildfire. Shusterman D; Kaplan JZ; Canabarro C West J Med; 1993 Feb; 158(2):133-8. PubMed ID: 8434462 [TBL] [Abstract][Full Text] [Related]
52. Impact of Fine Particulate Matter (PM2.5) Exposure During Wildfires on Cardiovascular Health Outcomes. Haikerwal A; Akram M; Del Monaco A; Smith K; Sim MR; Meyer M; Tonkin AM; Abramson MJ; Dennekamp M J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26178402 [TBL] [Abstract][Full Text] [Related]
53. Body mass index and response to emergency department treatment in adults with severe asthma exacerbations: a prospective cohort study. Rodrigo GJ; Plaza V Chest; 2007 Nov; 132(5):1513-9. PubMed ID: 17890469 [TBL] [Abstract][Full Text] [Related]
54. Impact of omalizumab on emergency-department visits, hospitalizations, and corticosteroid use among patients with uncontrolled asthma. Lafeuille MH; Dean J; Zhang J; Duh MS; Gorsh B; Lefebvre P Ann Allergy Asthma Immunol; 2012 Jul; 109(1):59-64. PubMed ID: 22727159 [TBL] [Abstract][Full Text] [Related]
55. Risk of recurrent emergency department visits or hospitalizations in children with asthma receiving nebulized budesonide inhalation suspension compared with other asthma medications. McLaughlin T; Leibman C; Patel P; Camargo CA Curr Med Res Opin; 2007 Jun; 23(6):1319-28. PubMed ID: 17559731 [TBL] [Abstract][Full Text] [Related]
56. Clinical symptoms and 'off-label' prescribing in children with asthma. McCowan C; Hoskins G; Neville RG Br J Gen Pract; 2007 Mar; 57(536):220-2. PubMed ID: 17359609 [TBL] [Abstract][Full Text] [Related]
57. Outcomes of patients treated with fluticasone propionate or montelukast sodium. Allen-Ramey FC; Duong PT; Goodman DC; Sajjan SG; Nelsen LM; Markson L Manag Care Interface; 2003 Aug; 16(8):30-5. PubMed ID: 12964550 [TBL] [Abstract][Full Text] [Related]
58. Hypertension and Asthma: A Comorbid Relationship. Christiansen SC; Schatz M; Yang SJ; Ngor E; Chen W; Zuraw BL J Allergy Clin Immunol Pract; 2016; 4(1):76-81. PubMed ID: 26342745 [TBL] [Abstract][Full Text] [Related]
59. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study. Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690 [TBL] [Abstract][Full Text] [Related]
60. Asthma population management: development and validation of a practical 3-level risk stratification scheme. Schatz M; Nakahiro R; Jones CH; Roth RM; Joshua A; Petitti D Am J Manag Care; 2004 Jan; 10(1):25-32. PubMed ID: 14738184 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]